DOC Stock Analysis — Healthpeak Properties
Sector: Healthcare REIT
AI Verdict
DOC trades at 78.8x next year's earnings while profits are expected to shrink, so you're paying a huge premium for stability that the numbers don't justify.
Competitive Moat
Healthpeak owns and operates a portfolio of high-quality medical office buildings and life science properties, benefitting from long-term leases to healthcare tenants with high switching costs. Its defensibility comes from the specialized nature of its properties, which are difficult and costly for competitors to replicate in prime medical locations.
Summary
DOC's sky-high 85.8 RSI and 78.8x forward P/E signal a market chasing yield in healthcare real estate despite falling earnings.
Where It Stands
Healthpeak is up 18.05% over the past year, but trades at 78.8x next year's earnings—over 3.5x the healthcare sector median of 22x—while its RSI of 85.8 is deep into overbought territory.
Key Metrics
- RSI: 85.8 — Overbought
- Trailing P/E: 62.4x
- Forward P/E: 78.8x
- Earnings Growth: -0.2%
- Revenue Growth: +0.0%
- Market Cap: $13.7B
- Dividend Yield: 0.06%
- 1-Year Return: 18.05%
- 52-Week High: $19.91
- 52-Week Low: $15.70
Analyst Consensus
12 Buy · 12 Hold · 0 Sell (24 analysts)
Bull Case
The 18.05% one-year return shows investors have rewarded DOC’s defensive healthcare property focus despite just 2.7% revenue growth.
Bear Case
With forward EPS expected to drop -20.9% and the forward P/E at 78.8x, even a modest multiple compression to the sector median 22x would imply a 72% downside risk.
Catalyst to Watch
Watch for the next quarterly earnings update—any further EPS guidance cuts or tenant instability could trigger a sharp valuation reset.